Search results
New study provides the "definitive answer on masks." They work.
Boing Boing· 2 days agoThe paper, which is based on a narrative review and meta-analysis research project, was written by...
California Supreme Court Sides With Insurer in COVID-19 Loss Case | The Recorder
Law.com· 3 days agoThe presence of the COVID-19 virus at a business does not automatically trigger insurance loss coverage, even if the establishment was forced to close, the California Supreme Court held Thursday ...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 3 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 4 days agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
CureVac (NASDAQ:CVAC) Sees Large Volume Increase
ETF DAILY NEWS· 2 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 290,327 shares traded hands during mid-day trading, a decline of 63% from the ...
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted...
Nutraingredients.com· 6 days agoNumerous studies have shown how the coronavirus infection can cause medium and long-term effects, generally known as “chronic COVID syndrome” or “Long-COVID”. One of the most common symptoms ...
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
KTLA-TV Los Angeles· 3 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
FOX 23 News Albany· 2 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...